LBF18109AM01: Difference between revisions

No edit summary
No edit summary
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Lipid/Header}}
{{Hierarchy|{{PAGENAME}}}}
{{Hierarchy|{{PAGENAME}}}}
{{Lipid/Header}}


{{Metabolite
{{Metabolite
|LipidBank=XPR7014
|LipidBank=XPR7014
|LipidMaps=-
|LipidMaps=-
|SysName=oleoylamide
|SysName=cis-9-Octadecenoic acidamide
|Common Name=&&oleoylamide&&
|Common Name=&&Oleoylamide&&Octadecenamide&&9Z-Octadecenoic acidamide&&
|Melting Point=74-75°C[[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|Melting Point=74-75°C[[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H NMR (CDCl3) <FONT FACE="Symbol">d</FONT>5.42 (br s, 2H), 5.32-5.36 (m, 2H), 2.22 (t, J=7.8 Hz 2H), 1.98-2.02 (m,6H), 1.62-1.66 (m, 4H), 1.27-1.31 (m, 16H), 0.88 (t, J=6.9Hz, 3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|NMR Spectra=^1 H NMR (CDCl3) delta 5.42 (br s, 2H), 5.32-5.36 (m, 2H), 2.22 (t, J=7.8 Hz 2H), 1.98-2.02 (m,6H), 1.62-1.66 (m, 4H), 1.27-1.31 (m, 16H), 0.88 (t, J=6.9Hz, 3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|Source=
|Chemical Synthesis=This compound was synthesized from oleic acid and ammonium hydroxide in 60 % yield.[[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
|Metabolism=
|Biological Activity=Binding of this compound to the brain cannabinoid receptor (CBl)was not found. [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]]
}}
}}


{{Lipid/Footer}}
{{Lipid/Footer}}

Latest revision as of 04:30, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



Oleoylamide
LBF18109AM01.png
Structural Information
cis-9-Octadecenoic acidamide
  • Oleoylamide
  • Octadecenamide
  • 9Z-Octadecenoic acidamide
Formula C18H35NO
Exact Mass 281.271864747
Average Mass 281.47664
SMILES CCCCCCCCC=CCCCCCCCC(N)=O
Physicochemical Information
74-75°C Sheskin_T et al.
This compound was synthesized from oleic acid and ammonium hydroxide in 60 % yield. Sheskin_T et al.
Binding of this compound to the brain cannabinoid receptor (CBl)was not found. Sheskin_T et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra 1H NMR (CDCl3) δ 5.42 (br s, 2H), 5.32-5.36 (m, 2H), 2.22 (t, J=7.8 Hz 2H), 1.98-2.02 (m,6H), 1.62-1.66 (m, 4H), 1.27-1.31 (m, 16H), 0.88 (t, J=6.9Hz, 3H). SheskinTet al.
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF18109AM01 See above. Sheskin_T et al. 1997